Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Pathogenic Germline Variants in 10,389 Adult Cancers
The Cancer Genome Atlas Research Network
McDonnell Genome Institute (MGI)
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Division of Nephrology
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
COVID-19 Researchers
Section of Medical Oncology
Division of Public Health Sciences
Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
Section of Computational Biology
Section of Stem Cell Biology
Institute for Public Health
Division of Oncology
Rheumatic Diseases Research Resource-Based Center
Center of Regenerative Medicine
DBBS - Human and Statistical Genetics
DBBS - Molecular Genetics and Genomics
DBBS - Immunology
DBBS - Molecular Cell Biology
DBBS - Cancer Biology
DBBS - Biomedical Informatics and Data Science
DBBS - Developmental, Regenerative and Stem Cell Biology
DBBS - Computational and Systems Biology
Hope Center for Neurological Disorders
Mentorship to Enhance Development in Academia Program
Washington University in St. Louis
Department of Mechanical Engineering & Materials Science
McKelvey School of Engineering
Section of Hematological Malignancies
Center for Advancing Health Services, Policy & Economics Research (CAHSPER)
Research output
:
Contribution to journal
›
Article
›
peer-review
645
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pathogenic Germline Variants in 10,389 Adult Cancers'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Loss of Heterozygosity
100%
Gene Expression
100%
In Cancer
100%
Adult Cancer
100%
Pathogenic Germline Variant
100%
Cancer Types
50%
Functional Consequences
50%
Large Deletion
50%
Tumor Suppressor
50%
Colocalization
50%
Cancer Association
50%
Likely Pathogenic Variant
50%
Breast Cancer Susceptibility Gene 1 (BRCA1)
50%
PALB2
50%
Oncogene
50%
Melanoma
50%
Two-hit
50%
Integrative Approach
50%
PTPN11
50%
Pan-cancer Analysis
50%
Frequency Loss
50%
Germline Variants
50%
Biallelic
50%
Germline Genetic Testing
50%
Variant Classification
50%
Expression Effects
50%
Stomach Adenocarcinoma
50%
Control Frequency
50%
Biochemistry, Genetics and Molecular Biology
Germline
100%
Germ Cell
100%
Gene Expression
66%
Loss of Heterozygosity
66%
Tumor Suppressor Protein
33%
Oncogene
33%
BRCA1
33%
PALB2
33%
Genetic Screening
33%
PTPN11
33%
SDHA
33%
Pan-cancer
33%